Irritable Bowel Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS)
Condition: Irritable Bowel Syndrome Interventions: Dietary Supplement: Fibre 1 (combined fibres); Dietary Supplement: Fibre 2 (natural fibres); Dietary Supplement: Dietary Supplement: placebo Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust; Universidad Veracruzana; University of Liverpool Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2019 Category: Research Source Type: clinical trials
Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Dietary Supplement: MPH_active; Dietary Supplement: MPH_placebo Sponsors: Helse Møre og Romsdal HF; Haukeland University Hospital; University of Bergen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2019 Category: Research Source Type: clinical trials
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
Conditions: Irritable Bowel Syndrome; Irritable Bowel Syndrome With Diarrhea Interventions: Drug: Rifaximin; Device: Glucose and lactulose hydrogen breath testing Sponsors: University of Michigan; Commonwealth Diagnostics International, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2018 Category: Research Source Type: clinical trials
